Jump to navigation Jump to search
Line 47: Line 47:
{{ACContribs
{{ACContribs
|authors=P. Koullapis<sup>a</sup>, F. Lizal<sup>b</sup>, J. Jedelsky<sup>b</sup>, L. Nicolaou<sup>c</sup>, K. Bauer<sup>d</sup>, O. Sgrott<sup>e</sup>, M. Jicha<sup>b</sup>, M. Sommerfeld<sup>e</sup>, S. C. Kassinos<sup>a</sup>
|authors=P. Koullapis<sup>a</sup>, F. Lizal<sup>b</sup>, J. Jedelsky<sup>b</sup>, L. Nicolaou<sup>c</sup>, K. Bauer<sup>d</sup>, O. Sgrott<sup>e</sup>, M. Jicha<sup>b</sup>, M. Sommerfeld<sup>e</sup>, S. C. Kassinos<sup>a</sup>
|organisation=<sup>a</sup>Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus
|organisation=<br><sup>a</sup>Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus
}}
}}
{{ACHeader
{{ACHeader

Revision as of 08:33, 21 October 2019

Front Page

Description

Test Data

CFD Simulations

Evaluation

Best Practice Advice

Aerosol deposition in the human upper airways

Application Area 7: Biomedical Flows

Application Challenge AC7-01

Abstract

Knowledge of deposition characteristics in the human airways is important when assessing the impact of inhaled aerosols, that can be either atmospheric pollutants or aerosols intended for therapeutic purposes. Not only the total deposition, but also local depositions within individual parts of the lung are of interest. The application of computer models that are based on computational fluid dynamics for the prediction of aerosol deposition in the human airways has become very common nowadays. Despite their limitations, that are mainly associated to their high computational cost, CFD models offer significant advantages over in vitro / in vivo experiments. However, prior to their use CFD models need to be properly validated. This is the objective of the current application Challenge. Specifically, in vitro deposition measurements using positron emission tomography (PET) have been conducted in a human-based model of the upper airways during steady-state inhalation at flow rates of 15, 30 and 60 L/min. The flow conditions at these flowrates are in the transitional to turbulent regime. CFD simulations were carried out in the same geometry and under the same ventilation conditions. Two sets of simulations were performed: Large Eddy Simulations using the dynamic version of the Smagorinsky-Lilly subgrid scale model and RANS simulations using the k-ω-SST turbulence model. In both methods, the Lagrangian approach has been adopted to track spherical particles in the airway geometry and determine regional deposition patterns.

The methods and results described in the present Application Challenge are mainly adopted from Lizal et al. (2012) (experimental part) and Koullapis et al. (2018) (numerical part).

This Application Challenge is based upon work from COST Action MP1404 SimInhale 'Simulation and pharmaceutical technologies for advanced patient-tailored inhaled medicines', supported by COST (European Cooperation in Science and Technology). http://www.siminhale-cost.eu ; http://www.cost.eu

AC7-01 fig0.png




Contributed by: P. Koullapisa, F. Lizalb, J. Jedelskyb, L. Nicolaouc, K. Bauerd, O. Sgrotte, M. Jichab, M. Sommerfelde, S. C. Kassinosa — 
aDepartment of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus

Front Page

Description

Test Data

CFD Simulations

Evaluation

Best Practice Advice


© copyright ERCOFTAC 2019